跳至主要内容
临床试验/IRCT20091027002639N23
IRCT20091027002639N23已完成2 期

Evaluation of efficacy of topiramate alone and topiramate with omega-3 fatty acid in prophylaxis of headaches in 5-15 year old children with migraine

Yazd University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
5 years 至 15 years(—)
性别
All

入选标准

  • children aged 5-15 years old
  • having migraine headache based on International Headache Society Criteria
  • having one or more headache attack per week
  • having moderate or severe headache disability
  • have not received omega-3 combinations within the past two months
  • did not use any migraine preventive therapy

排除标准

  • secondary headaches such as epilepsy or other neurologic disorders
  • allergy to topiramat or omega-3
  • discontinuation of drugs usage for more than one week
  • irregullar drugs usage

研究者

发起方
Yazd University of Medical Sciences

相似试验